Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells - Marta Serafini; Sophie A. Twigger; George Delfas; Maxim Mallerman; Elliot P. Bailey; Ewen D. D. Calder; Ester M. Hammond; Stuart J. Conway (Journal of the American Chemical Society, 2025)